Cns Pharmaceuticals Inc (CNSP)

Dec 29, 2025

CNS Pharmaceuticals Inc. (CNSP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 29, 2025

Dec 28, 2025

CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Down 0.5% – Here’s Why - Defense World

Dec 28, 2025

Dec 27, 2025

Aug Reactions: How CNS Pharmaceuticals Inc stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn

Dec 27, 2025

Dec 23, 2025

CNS Pharmaceuticals names Rami Levin as new CEO following John Climaco’s departure - MSN

Dec 23, 2025

Dec 22, 2025

Whats Driving Tourism Finance Corporation of India Limited Stocks Recent Momentum Key TrendsCandlestick Trading Patterns & High Return Capital Strategies - earlytimes.in

Dec 22, 2025

Dec 20, 2025

Why CNS Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда

Dec 20, 2025

Dec 20, 2025

Will CNS Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Growth vs Value & Safe Entry Trade Signal Reports - Улправда

Dec 20, 2025

Dec 19, 2025

Is CNS Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Earnings Report & High Conviction Buy Zone Picks - Улправда

Dec 19, 2025

Dec 19, 2025

CNSP (CNS Pharmaceuticals) EV-to-OCF : 0.34 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Dec 18, 2025

CNSP (CNS Pharmaceuticals) EV-to-OCF : 0.34 (As of Dec. 18, 2025) - GuruFocus

Dec 18, 2025

Dec 18, 2025

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco By Investing.com - Investing.com South Africa

Dec 18, 2025

Dec 18, 2025

CNS Pharmaceuticals Announces New CEO Appointment - The Globe and Mail

Dec 18, 2025

Dec 17, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Appoints Rami Levin as President and CEO - Digital Journal

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals Appoints Rami Levin as CEO to Advance Brain Cancer Pipeline - citybuzz -

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals shares dip after CEO departure announcement - MSN

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO, John Climaco resigns By Investing.com - Investing.com Australia

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO effective Jan 1, 2026 - marketscreener.com

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals stock falls after CEO steps down - Investing.com India

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals stock falls after CEO steps down By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO, John Climaco resigns - Investing.com

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals Announces CEO Transition - TradingView — Track All Markets

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals (CNSP) appoints new CEO Rami Levin and outlines Climaco severance - Stock Titan

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals (CNSP) Appoints New CEO - GuruFocus

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco - Investing.com India

Dec 17, 2025

Dec 17, 2025

Brain cancer drug developer taps new CEO with global track record - Stock Titan

Dec 17, 2025

Dec 15, 2025

CNS Pharmaceuticals Earnings Notes - Trefis

Dec 15, 2025

Dec 12, 2025

Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld MedTech

Dec 12, 2025

Dec 11, 2025

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at 7th Annual CNS Delivery SummitSlideshow - Seeking Alpha

Dec 11, 2025

Dec 08, 2025

Transcript : Catalyst Pharmaceuticals, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 12 - marketscreener.com

Dec 08, 2025

Dec 05, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast - Digital Journal

Dec 05, 2025

Dec 05, 2025

Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 (PRAX) - Seeking Alpha

Dec 05, 2025

Dec 04, 2025

CNS Pharmaceuticals CEO Outlines Strategy to Target Glioblastoma by Overcoming Blood-Brain Barrier - citybuzz

Dec 04, 2025

Dec 03, 2025

Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics ... - Enidnews.com

Dec 03, 2025

Dec 03, 2025

Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference - GlobeNewswire

Dec 03, 2025

Dec 03, 2025

Will CNS Pharmaceuticals Inc. stock gain from lower inflationGold Moves & High Accuracy Trade Alerts - Newser

Dec 03, 2025

Dec 02, 2025

CNS Pharma (CNSP) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Dec 02, 2025

Acumen and JCR Advance Next-Generation CNS Therapeutics with EBD™ Technology - citybiz

Dec 02, 2025

Dec 02, 2025

CNS Pharmaceuticals, Inc. (CNSP) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Dec 02, 2025

Dec 01, 2025

Alector to Participate in the Bank of America CNS Therapeutics Conference - Yahoo Finance

Dec 01, 2025

Nov 29, 2025

What analysts say about CNS Pharmaceuticals Inc stockGrowth vs. Value Investing & High Profit Investment Ideas - earlytimes.in

Nov 29, 2025

Nov 27, 2025

Where Analysts See Bemco Hydraulics Limited Stock by YearEndRisk-Reward Ratio Analysis & Free Rapid Return Acceleration - earlytimes.in

Nov 27, 2025

Nov 26, 2025

Bank of America CNS Therapeutics Virtual Conference - marketscreener.com

Nov 26, 2025

Nov 26, 2025

CNS Pharmaceuticals, Inc.Common Stock (NQ: CNSP - Markets Financial Content

Nov 26, 2025

Nov 24, 2025

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - The Manila Times

Nov 24, 2025

Nov 22, 2025

CNS Pharmaceuticals Increases Authorized Shares for Growth - The Globe and Mail

Nov 22, 2025

Nov 22, 2025

CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting - Investing.com Australia

Nov 22, 2025

Nov 21, 2025

CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting By Investing.com - Investing.com South Africa

Nov 21, 2025